Company intelligence / Profile preview

Vecotech

London, United Kingdom

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Vecotech is a biotechnology company specializing in the development of innovative products to control vector-borne diseases and pests. Spun out from the London School of Hygiene & Tropical Medicine, the company leverages expertise in chemical ecology to identify natural compounds that influence insect behavior. Their portfolio includes advanced insect repellents and the BugScents bed bug lure, which utilizes synthetic pheromones to detect infestations. Vecotech's research focuses on reducing the global burden of diseases such as malaria and Zika by targeting the sensory systems of disease-carrying insects.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeSemiochemicals
Industry: Non-Drug Biotech

Partnerships

London School of Hygiene & Tropical MedicineRothamsted Research

Beyond the preview

Go deeper on Vecotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vecotech.

Explore the full profile